In this review, Gerard Drewes discusses novel experimental strategies to the discovery of epigenetic drug targets based on assays which more closely reflect physiological complexity. The author outlines different approaches towards the unbiased discovery of small molecule probes for targets that are relevant in the modulation of disease-relevant cellular and epigenetic processes. He also discusses the recent progress in the application of chemical probes in drug discovery utilizing native cellular proteins and protein complexes.